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Introduction  
Metallic implants such as titanium alloy have been widely 
used in orthopaedic surgeries
1
. 2-5% of the patients 
acquire post-operative bacterial infections at implant site 
though prescription of antibiotics
2
. Patients may suffer 
from surgeries like debridement of wound, removal of 
problematic implant and insertion of new implant. 
To reduce bacterial infections and improve quality of life 
of patients, implant surfaces loaded with antibiotics
3
, 
TiO2
4
, Ag or Cu ions
5
 were developed. None has been 
successful due to durability or compatibility of released 
ions to surrounding tissues. We therefore aim to develop a 
biocompatible surface with antibacterial functions by 
incorporating novel peptide onto the Ti alloy surface.  
 
Materials and Methods 
Materials Fabrication 5mm diameter medical grade Ti-
6Al-4V discs were mirror polished, oxidized to Ti-OH
6
, 
then converted to Ti-OSi-(CH2)3-NH2
7
. Novel peptide 
(patent pending) was then covalently incorporated onto 
the Ti surfaces.  
Biocompatibility Evaluation In the osteoblast adhesion 
test, 4,000 green fluorescent protein osteoblast from mice 
were applied on each sample and incubated at 37℃ for 
10hrs. The adhered cells were examined under fluorescent 
microscope.  
In the MTT assay, 30,000 MC3T3-E1 pre-osteoblast cells 
were applied on each sample and standard MTT 
procedures were conducted to evaluate the cytotoxicity at 
36hrs. Absorbance values of cells attached on culture 
wells and medium without cells serve as the positive and 
negative controls. Independent-samples t test was applied 
to evaluate the statistical difference.  
Antibacterial Activity Assessment Samples were incubated 
with 10
5
 Staphylococcus aureus cells at 37℃ for 30min. 
The adhered bacteria were fluorescent stained and the 
density of live bacteria on the treated surfaces were 
compared with the untreated controls.  
Results 
Osteoblast adhesion test 
   
Fig. 1: Osteoblast cells adhered on 
untreated and treated surfaces (scale 
bar: 200μm). The micrographs show 
that density of adhered osteoblast 
were similar on all tested surfaces.  
 
MTT assay 
 
Fig. 2: MTT results of untreated and treated surfaces. No 
significant difference exists between all treated and 
untreated surfaces. This indicates a lack of cytotoxicity in 
the intermediate linker and the final peptide surfaces.  
Antibacterial test 
 
Fig. 3 Density of bacteria attached on untreated and 
peptide treated surfaces. The density of bacteria on the 
peptide-Ti surfaces was significantly different from the 
untreated control. The incorporation of novel peptide 
reduced bacterial adhesion by 52%. 
Discussion and Conclusions 
We successfully improve the antibacterial activity of a 
biocompatible surface by 52% through incorporating 
novel peptide. This surface treatment is potentially useful 
as it reduces bacterial infections and thereby encourages 
proper functioning of the implants. With fewer chances of 
getting infected, we improve the quality of life of patients. 
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